Collectively, these studies underscore the critical role of eosinophil and IL-5RA signaling in IBD pathogenesis, with IL-5RA antagonist demonstrating significant potential in improving disease outcomes in DSS-induced colitis models. The gene discussed is IL5RA; the disease is inflammatory bowel disease.